Cryptosporidum parvum is an intracellular protozoan parasite that causes en
teric infection and diarrhea in a wide range of mammalian hosts, including
humans and economically important livestock species. There are no effective
vaccines or drug treatments available for cryptosporidiosis. Cryptosporidi
um parvum utilizes a unique metabolic pathway for the synthesis of polyamin
es, forming agmatine as an intermediary metabolite. We treated infant mice
with oral doses of agmatine for 2 days before, the day of, and 5 days follo
wing experimental infection with C. parvum. Mice treated with agmatine were
significantly less infected with C. parvum than were control mice receivin
g phosphate-buffered saline. Mice treated with agmatine only on the day of
experimental infection with C. parvum were also significantly less infected
than were control mice. These data suggest that exogenous agmatine alters
the metabolism of C. parvum sufficient to interfere with its ability to col
onize the mammalian intestine.